CVS Health Corporation (CVS) News
Filter CVS News Items
CVS News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
CVS News Highlights
- For CVS, its 30 day story count is now at 24.
- Over the past 20 days, the trend for CVS's stories per day has been choppy and unclear. It has oscillated between 1 and 7.
- EYE, DRUG and SE are the most mentioned tickers in articles about CVS.
Latest CVS News From Around the Web
Below are the latest news stories about CVS HEALTH CORP that investors may wish to consider to help them evaluate CVS as an investment opportunity.
UPDATE 2-Instacart valued at $9.9 bln as IPO market reboundsMaplebear Inc, the parent of grocery delivery app Instacart, disclosed on Monday it fetched a $9.9 billion fully diluted valuation after pricing its initial public offering (IPO) at the top of its indicated range. The valuation is a fraction of the $39 billion value that investors assigned to Instacart in a private fundraising round in March 2021, at the height of the COVID-19 pandemic which pushed consumers to order groceries at home. The offering is the last sign of the U.S IPO market's rebound, which was arid for most of this year and 2022, until SoftBank Group Corp's chip designer Arm floated on Nasdaq last week at a $54.5 billion fully diluted valuation. |
3 Strong Sell Stocks for September 2023These 3 stocks to avoid aren't offering much right now – except uncertainty and massive risk of potential losses. |
Betting With the ‘Big Short’: 3 Michael Burry Stocks to Bank OnBurry's insight and strategic thinking led him to invest in three seemingly disparate industries. |
CVS Health's (CVS) New COVID-19 Vaccine Available at Its StoresCVS Health's (CVS) updated mRNA COVID-19 vaccine is now available at all its pharmacy locations. |
2 Top Stocks to Buy Near Their 52-Week LowsThe market is putting up a strong performance this year with the S&P 500 gaining 16% as of this writing. That's a far cry from what we saw for most of 2022 when equities experienced a painful downturn. |
3 S&P 500 Stocks to Sell Before a CrashHere's a list of S&P 500 stocks to sell. |
CVS Health (CVS) Stock Sinks As Market Gains: What You Should KnowCVS Health (CVS) closed at $70.24 in the latest trading session, marking a -0.4% move from the prior day. |
After Walgreens CEO's sudden exit, chain makes a major move that will help youEarlier this month, Walgreens CEO Rosalind Brewer abruptly resigned after less than three years at the post. "Roz navigated the company through the global pandemic, overseeing the critical rollout of vaccines in Walgreens pharmacies and to high-risk populations across the country," Executive Chairman Stefano Pessina said of Brewer following her departure. In her resignation, Brewer said "I look forward to watching the company continue its transformation to deliver localized health care." |
FDA warns CVS to stop selling unauthorized 'pinkeye' eyedropsCVS Health Corp. has been advised to clear illegally marketed and unapproved eyedrops from its shelves and its website. The U.S. Food and Drug Administration on Monday issued warning letters to eight companies, including the Woonsocket-based CVS (NYSE:CVS), for manufacturing or marketing unapproved ophthalmic drug products in violation of federal law. “The FDA has observed that your website offers 'CVS Health Pink Eye Relief Drops' for sale in the United States,” states the letter from FDA compliance officer Jill Furman to CVS chief executive Karen Lynch. |
UPDATE 1-US pharmacy chains gear up to administer updated COVID shotsU.S. drugstore chains CVS Health and Walgreens Boots Alliance said on Wednesday that updated COVID-19 vaccines would be available at their stores as soon as this week. Shots were being delivered in some locations on Wednesday, including at a Northwell Health facility in New York. The U.S. Centers for Disease Control and Prevention (CDC) director on Tuesday signed off on broad use of updated COVID-19 vaccines, arming a push to align the next round of shots more closely with the circulating variant of the virus, much like annual flu shots are designed. |